乐观
$3.66
情景价格
$4.630
+0.071 (+1.54%)收盘时
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.
Clover Health Investments Corp is a good buy right now, trading at $4.60 with a forward P/E of 37.74, indicating growth potential. The stock has shown a remarkable YTD change of +90.87%, reflecting strong investor interest and performance. Additionally, the company has recently earned top honors in Medicare Advantage ratings, which could enhance its market position. The main risk is the negative EPS estimate of -0.01 for the upcoming earnings report on November 4, 2026, which could impact short-term sentiment.
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Clover Health Earns Top Honors in Medicare Advantage Ratings

Medicare Star Ratings Shift Impacts Stock Prices

Alignment Healthcare Shares Plunge 22% Amidst Overhaul Challenges

Humana's 2026 Profit Expected to Drop by $3.5 Billion

Latest Wall Street Ratings Overview
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Clover Health Investments Corp is a good buy right now, trading at $4.60 with a forward P/E of 37.74, indicating growth potential. The stock has shown a remarkable YTD change of +90.87%, reflecting strong investor interest and performance. Additionally, the company has recently earned top honors in Medicare Advantage ratings, which could enhance its market position. The main risk is the negative EPS estimate of -0.01 for the upcoming earnings report on November 4, 2026, which could impact short-term sentiment.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。